Small disconnects between clinical ops and supply chain can derail complex trials. Strong alignment keeps forecasts accurate, supply on track, and patients supported.
- How Exit Strategy Should Shape Clinical Trial Supply Planning
- This Assumption Will Break Your Clinical Trial
- When Clinical Supply Fails, Small Biotech Trials Stall
- Putting Vaccine Supply Resilience To The Test: The Last Mile
- How Clinical Supply Drives Resilience In Global Vaccine Networks
- From Inconsistency To Structure: A Model For Defensible Compliance Decisions
- Building Resilient Clinical Supply Chains To Keep Trials On Track
- Randomization And Trial Supply Management (RTSM) Systems: Meet Your Neighbor Again
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Changing Dynamics Of The Pharma/Biotech Supply Chain – A Packaging And Clinical Supply Perspective
Perhaps more than any other industry, pharma and biotech have undergone radical change over the past year, as a result of the COVID-19 pandemic. From supply chain security and capacity to clinical trial operations and site auditing, almost every aspect has been affected. Experts explore how these trends are shaping the industry and offer an outlook.
-
How Clinical Trial Complexity Impacts End Users
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
CDMO Support: Success In Early-Phase Drug Product Development
As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.
-
Study, Not Software: Aligning RTSM To The Protocol
How can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?
-
How CDMOs Deliver Precision and Scale in Pharma Spray Drying
Spray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
Advancing Your API To First Human Dose Trials More Efficiently
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Faster From Formulation To Fill/Finish
Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
Data Analytics For Better ClinRO Quality
Many trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality.
-
Outgrowing Excel: Implementing RTSM In A Live Phase I Trial
Learn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
Driving Successful Obesity Drug Development With GLP-1 Agonists
GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.